Evidence map›Paper›PMID 25742655›Full record

ArticlePloS one2015

Quantification of cellular NEMO content and its impact on NF-κB activation by genotoxic stress.

Byounghoon Hwang, Funita P Phan, Kevin McCool, Eun Young Choi, Jinsam You, Adam Johnson, Anjon Audhya, Shigeki Miyamoto

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Byounghoon HwangDepartment of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America.
Funita P PhanDepartment of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America; Integrated Program in Biochemistry, University of Wisconsin, Madison, Wisconsin, United States of America.
Kevin McCoolDepartment of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America; Molecular and Cellular Pharmacology, University of Wisconsin, Madison, Wisconsin, United States of America.
Eun Young ChoiDepartment of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America.
Jinsam YouDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Adam JohnsonIntegrated Program in Biochemistry, University of Wisconsin, Madison, Wisconsin, United States of America; Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, United States of America.
Anjon AudhyaDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, United States of America.
Shigeki MiyamotoDepartment of Oncology, University of Wisconsin, Madison, Wisconsin, United States of America; Integrated Program in Biochemistry, University of Wisconsin, Madison, Wisconsin, United States of America; Molecular and Cellular Pharmacology, University of Wisconsin, Madison, Wisconsin, United States of America.
University of Wisconsin–Madison · USIndiana University School of Medicine

Funding

Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
Regulation of NEMO modifications in radiation-induced NF-kB signalingR01CA077474 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2000 to 2014
$4.0M
Regulatory mechanisms that control vesicle secretion at the endoplasmic reticulumR01GM110567 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 2015 to 2019
$1.8M
Regulation of NF-kappaB by Small Ubiquitin-Like ModifiersR01GM083681 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2010 to 2013
$1.1M
NCI NIH HHS R01 CA077474NCI NIH HHS T32 CA009135NIGMS NIH HHS R01 GM083681NIGMS NIH HHS R01 GM110567NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

NF-κB essential modulator, NEMO, plays a key role in canonical NF-κB signaling induced by a variety of stimuli, including cytokines and genotoxic agents. To dissect the different biochemical and functional roles of NEMO in NF-κB signaling, various mutant forms of NEMO have been previously analyzed. However, transient or stable overexpression of wild-type NEMO can significantly inhibit NF-κB activation, thereby confounding the analysis of NEMO mutant phenotypes. What levels of NEMO overexpression lead to such an artifact and what levels are tolerated with no significant impact on NEMO function in NF-κB activation are currently unknown. Here we purified full-length recombinant human NEMO protein and used it as a standard to quantify the average number of NEMO molecules per cell in a 1.3E2 NEMO-deficient murine pre-B cell clone stably reconstituted with full-length human NEMO (C5). We determined that the C5 cell clone has an average of 4 x 10(5) molecules of NEMO per cell. Stable reconstitution of 1.3E2 cells with different numbers of NEMO molecules per cell has demonstrated that a 10-fold range of NEMO expression (0.6-6x10(5) molecules per cell) yields statistically equivalent NF-κB activation in response to the DNA damaging agent etoposide. Using the C5 cell line, we also quantified the number of NEMO molecules per cell in several commonly employed human cell lines. These results establish baseline numbers of endogenous NEMO per cell and highlight surprisingly normal functionality of NEMO in the DNA damage pathway over a wide range of expression levels that can provide a guideline for future NEMO reconstitution studies.

Indexed as

AnimalsCell LineDNA DamageHumansI-kappa B KinaseMiceNF-kappa BPrecursor Cells, B-LymphoidSignal TransductionI-kappa B KinaseIKBKG protein, humanNF-kappa B

Identifiers

PMID25742655
PMCPMC4350935
OpenAlexW2084606915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.